Head of Development Established Dosage Forms

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a longterm perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. The Position We are looking for a dynamic and experienced professional to take on the role as Head Development Established Dosage Forms in our esteemed pharmaceutical company. In this position, you will have the opportunity to showcase your leadership skills, set new standards, and contribute to the advancement of cuttingedge pharmaceutical development platforms. With a strong focus on solid and semisolid preparations, you will play a pivotal role in shaping the future of drug product development. Your impact will extend to the development of pharmaceutical products with a wide range of budgets, from 20 to upward of 500

---